Home/NGM Biopharmaceuticals/Robert (Bob) J. Thorne, Ph.D.
R(

Robert (Bob) J. Thorne, Ph.D.

Co-Founder, Advisor & Board Member

NGM Biopharmaceuticals

NGM Biopharmaceuticals Pipeline

DrugIndicationPhase
NGM120Hyperemesis GravidarumPhase 2
NGM831 (MK-3655)Metabolic Dysfunction-Associated Steatohepatitis (MASH)Phase 2b
NGM621Geographic Atrophy (GA)Phase 2
NGM438Genetic LipodystrophyPreclinical